154 related articles for article (PubMed ID: 31399283)
1. Autoantibodies detected in patients with vitiligo vulgaris but not in those with rhododendrol-induced leukoderma.
Arase N; Tanemura A; Jin H; Nishioka M; Aoyama Y; Oiso N; Matsunaga K; Suzuki T; Nishigori C; Kawamura T; Shimizu T; Ito A; Fukai K; Abe Y; Yang L; Tsuruta D; Takeoka K; Iwatani Y; Hidaka Y; Nishida M; Yamauchi-Takihara K; Arase H; Fujimoto M; Katayama I
J Dermatol Sci; 2019 Aug; 95(2):80-83. PubMed ID: 31399283
[No Abstract] [Full Text] [Related]
2. Rhododendrol-induced leukoderma accompanied by allergic contact dermatitis caused by a non-rhododendrol skin-lightening agent, 5,5'-dipropylbiphenyl-2,2'-diol.
Yagami A; Suzuki K; Sano A; Takahashi M; Kobayashi T; Morita Y; Ando A; Iwata Y; Matsunaga K
J Dermatol; 2015 Jul; 42(7):739-40. PubMed ID: 25875673
[No Abstract] [Full Text] [Related]
3. Possible involvement of CCR4+ CD8+ T cells and elevated plasma CCL22 and CCL17 in patients with rhododenol-induced leukoderma.
Nishioka M; Tanemura A; Yang L; Tanaka A; Arase N; Katayama I
J Dermatol Sci; 2015 Mar; 77(3):188-90. PubMed ID: 25766765
[No Abstract] [Full Text] [Related]
4. The spectrophotometrical analysis of rhododendrol-induced leucoderma using a novel multispectral camera.
Inoue M; Kikuchi K; Watabe A; Yamasaki K; Aiba S
Br J Dermatol; 2016 Aug; 175(2):334-9. PubMed ID: 26991967
[TBL] [Abstract][Full Text] [Related]
5. Biochemical, cytological, and immunological mechanisms of rhododendrol-induced leukoderma.
Tokura Y; Fujiyama T; Ikeya S; Tatsuno K; Aoshima M; Kasuya A; Ito T
J Dermatol Sci; 2015 Mar; 77(3):146-9. PubMed ID: 25726326
[TBL] [Abstract][Full Text] [Related]
6. Open-label pilot study to evaluate the effectiveness of topical bimatoprost on rhododendrol-induced refractory leukoderma.
Fukaya S; Kamata M; Kasanuki T; Yokobori M; Takeoka S; Hayashi K; Tanaka T; Fukuyasu A; Ishikawa T; Ohnishi T; Iimuro S; Tada Y; Watanabe S
J Dermatol; 2018 Nov; 45(11):1283-1288. PubMed ID: 30156328
[TBL] [Abstract][Full Text] [Related]
7. Retention of pigment stem cells in Rhododenol-induced leukoderma: Pathological investigation of 11 patients.
Watanabe S; Yagami A; Iwata Y; Nagai A; Kuroda M; Sugiura K; Matsunaga K
J Dermatol; 2017 Jul; 44(7):e148-e149. PubMed ID: 28516676
[No Abstract] [Full Text] [Related]
8. Efficacy of oral cholecalciferol on rhododendrol-induced vitiligo: A blinded randomized clinical trial.
Watabe A; Yamasaki K; Asano M; Kanbayashi Y; Nasu-Tamabuchi M; Terui H; Furudate S; Kakizaki A; Tsuchiyama K; Kimura Y; Ito Y; Kikuchi K; Aiba S
J Dermatol; 2018 Apr; 45(4):456-462. PubMed ID: 29399865
[TBL] [Abstract][Full Text] [Related]
9. Chemical-Induced Vitiligo.
Harris JE
Dermatol Clin; 2017 Apr; 35(2):151-161. PubMed ID: 28317525
[TBL] [Abstract][Full Text] [Related]
10. An immune pathological and ultrastructural skin analysis for rhododenol-induced leukoderma patients.
Tanemura A; Yang L; Yang F; Nagata Y; Wataya-Kaneda M; Fukai K; Tsuruta D; Ohe R; Yamakawa M; Suzuki T; Katayama I
J Dermatol Sci; 2015 Mar; 77(3):185-8. PubMed ID: 25676426
[TBL] [Abstract][Full Text] [Related]
11. Clinical and epidemiological analysis in 149 cases of rhododendrol-induced leukoderma.
Yoshikawa M; Sumikawa Y; Hida T; Kamiya T; Kase K; Ishii-Osai Y; Kato J; Kan Y; Kamiya S; Sato Y; Yamashita T
J Dermatol; 2017 May; 44(5):582-587. PubMed ID: 27882588
[TBL] [Abstract][Full Text] [Related]
12. Immunohistopathological analysis of frizzled-4-positive immature melanocytes from hair follicles of patients with Rhododenol-induced leukoderma.
Okamura K; Ohe R; Abe Y; Ueki M; Hozumi Y; Tamiya G; Matsunaga K; Yamakawa M; Suzuki T
J Dermatol Sci; 2015 Nov; 80(2):156-8. PubMed ID: 26277630
[No Abstract] [Full Text] [Related]
13. The effect of rhododendrol inhibition of NF-κB on melanocytes in the presence of tyrosinase.
Arase N; Yang L; Tanemura A; Yang F; Suenaga T; Arase H; Katayama I
J Dermatol Sci; 2016 Aug; 83(2):157-9. PubMed ID: 27174091
[No Abstract] [Full Text] [Related]
14. Melanocyte-specific cytotoxic T lymphocytes in patients with rhododendrol-induced leukoderma.
Fujiyama T; Ikeya S; Ito T; Tatsuno K; Aoshima M; Kasuya A; Sakabe J; Suzuki T; Tokura Y
J Dermatol Sci; 2015 Mar; 77(3):190-2. PubMed ID: 25724360
[No Abstract] [Full Text] [Related]
15. Zebrafish as a new model for rhododendrol-induced leukoderma.
Hayazaki M; Hatano O; Shimabayashi S; Akiyama T; Takemori H; Hamamoto A
Pigment Cell Melanoma Res; 2021 Nov; 34(6):1029-1038. PubMed ID: 34310852
[TBL] [Abstract][Full Text] [Related]
16. Glutathione maintenance is crucial for survival of melanocytes after exposure to rhododendrol.
Kondo M; Kawabata K; Sato K; Yamaguchi S; Hachiya A; Takahashi Y; Inoue S
Pigment Cell Melanoma Res; 2016 Sep; 29(5):541-9. PubMed ID: 27223685
[TBL] [Abstract][Full Text] [Related]
17. Substantial evidence for the rhododendrol-induced generation of hydroxyl radicals that causes melanocyte cytotoxicity and induces chemical leukoderma.
Gabe Y; Miyaji A; Kohno M; Hachiya A; Moriwaki S; Baba T
J Dermatol Sci; 2018 Sep; 91(3):311-316. PubMed ID: 30005897
[TBL] [Abstract][Full Text] [Related]
18. Rhododendrol-induced leukoderma update II: Pathophysiology, mechanisms, risk evaluation, and possible mechanism-based treatments in comparison with vitiligo.
Inoue S; Katayama I; Suzuki T; Tanemura A; Ito S; Abe Y; Sumikawa Y; Yoshikawa M; Suzuki K; Yagami A; Masui Y; Ito A; Matsunaga K
J Dermatol; 2021 Jul; 48(7):969-978. PubMed ID: 33951216
[TBL] [Abstract][Full Text] [Related]
19. Guide for medical professionals (i.e., dermatologists) for the management of Rhododenol-induced leukoderma.
Nishigori C; Aoyama Y; Ito A; Suzuki K; Suzuki T; Tanemura A; Ito M; Katayama I; Oiso N; Kagohashi Y; Sugiura S; Fukai K; Funasaka Y; Yamashita T; Matsunaga K
J Dermatol; 2015 Feb; 42(2):113-28. PubMed ID: 25622988
[TBL] [Abstract][Full Text] [Related]
20. 4-(4-hydroroxyphenyl)-2-butanol (rhododendrol) activates the autophagy-lysosome pathway in melanocytes: insights into the mechanisms of rhododendrol-induced leukoderma.
Yang L; Yang F; Wataya-Kaneda M; Tanemura A; Tsuruta D; Katayama I
J Dermatol Sci; 2015 Mar; 77(3):182-5. PubMed ID: 25680854
[No Abstract] [Full Text] [Related]
[Next] [New Search]
